Hunan Fangsheng Pharmaceutical Co., Ltd. (SHA:603998)

China flag China · Delayed Price · Currency is CNY
9.73
+0.34 (3.62%)
Jul 3, 2026, 3:00 PM CST
Market Cap4.27B -7.2%
Revenue (ttm)1.79B +1.9%
Net Income306.52M +12.2%
EPS0.70 +12.9%
Shares Out 439.08M
PE Ratio13.90
Forward PE11.72
Dividend0.45 (4.62%)
Ex-Dividend DateMay 29, 2026
Volume10,290,000
Open9.52
Previous Close9.39
Day's Range9.43 - 9.74
52-Week Range8.64 - 13.50
Beta0.29
Analystsn/a
Price Targetn/a
Earnings DateAug 29, 2026

About SHA:603998

Hunan Fangsheng Pharmaceutical Co., Ltd. engages in research, develops, produces, and sells traditional Chinese medicine industry and chemical pharmaceutical products in China. The company offers pharmaceutical manufacturing; and provides cardiovascular and cerebrovascular drugs, skeletal muscle system drugs, orthopedic drugs, respiratory drugs, pediatric drugs, gynecological drugs, and anti-infective drugs. The company's main products include Xuesetong dispersible tablets, Xuesetong tablets, Garcinia bone-strengthening tablets, Dieda Huoxue ca... [Read more]

Sector Healthcare
Founded 2002
Employees 1,868
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603998
Full Company Profile

Financial Performance

In 2025, SHA:603998's revenue was 1.75 billion, a decrease of -1.75% compared to the previous year's 1.78 billion. Earnings were 306.39 million, an increase of 20.05%.

Financial Statements